C
ELLS BELONGING to the lymphoid lineages are instrumental in protecting their hosts against an enormous diversity of foreign agents. Of these, T and B cells are most extensively studied. The way these cells recognize foreign antigens through the T-cell receptor (TCR) and Igs is now well understood. These receptors are generated by gene rearrangements, providing T and B cells with an almost unlimited capacity to recognize potential pathogens. Several mechanisms exist to ensure that T and B cells stay indifferent towards self antigens and insight into how this is achieved is increasing. Cells belonging to the third lymphoid lineage, natural killer (NK) cells, are able to kill a wide variety of target cells, including tumor cells and cells infected with bacteria and viruses. The physiologic role of these cells is not fully understood, but it is generally believed that these cells form a first line of defense towards infections by cytolytic activity or the secretion of certain cytokines. NK cells do not possess rearranged receptor genes, but recent work has established that NK cells do have the capacity to recognize major histocompatibility complex (MHC) class I antigens in vitro and in vivo.' However, in contrast to T cells that are generally activated by the interaction between MHC/ peptide complexes and TCR, NK cells are turned off by interaction of their specific receptors with MHC class I antigens.
The developmental relationship of the three lymphoid lineages is not precisely known. Like all hematopoietic cells, the lymphoid lineages are derived from pluripotent stem cells, operationally defined not only by their capacity to give rise to blood cells but also to self-renew. A popular model of lymphoid differentiation postulates that when stem cells differentiate to mature lymphoid cells they pass through a common lymphoid progenitor cell. This still elusive cell type should be committed to the lymphoid lineages and should have lost the capacity to differentiate into any of the other hematopoietic cell lineages. Evidence for a separate regulation of lymphoid and myeloiderythroid development is provided by the observation that mice functionally deficient for the transcription factor Ikaros have myeloid and erythroid cells but lack T, B, and NK c e k 2 However, there is some evidence from studies with hematopoietic tumors that pre-B cells have not completely lost their capacity to develop into myeloid cells. 3 As an alternative to the idea of a fixed sequence of branchpoints involving irreversible differentia-tion steps, it has been proposed that during hematopoietic development the progenitor cells gradually, but not absolutely, restrict their lineage potential: Recent evidence, to be discussed below, suggests that T and NK cells are more related to each other than to B cells. This finding implies that if one accepts the model of fixed decision points, B cells branch from the developmental tree earlier than T and NK cells.
Information about the cell surface antigen phenotype of intermediate cell types in development of stem cells to mature lymphoid cells has accumulated from both human and animal studies. The human system has in principle the potential to be very informative for defining minute intermediate cell types in lymphoid development because of the availability of monoclonal antibodies against many more cell surface antigens than in the mouse. However, until recently, the lack of assays that could assess the capacity of putative progenitor cells to differentiate into mature lymphoid cells was a serious drawback of studies in human compared with animal models. Establishment of the SCID-hu mouse, originally described by McCune et has now paved the way for assays that measure the capacity of primitive hematopoietic progenitor cells to develop to T and B Moreover, in vitro fetal thymic organ culture (FTOC) systems have been devised that permit analysis of human T and NK development from primitive hematopoietic progenitor cells.""8 Finally CD34' progenitor cells can differentiate into NK cells in vitro when cultured in the presence of cytokines with or without stromal Application of these assays in combination with detailed phenotypic analyses have resulted in a rapid accumulation of information with regard to T and NK development in humans. In this review we will discuss the state of our understanding of human T and NK development. When appropriate, we will review relevant, related information from mouse models as well. Comprehensive reviews about murine T-cell development have been published elsewhere.'2~25 Ce~ls,17.19-21
DEVELOPMENT OF STEM CELLS TO EARLY T-CELL PROGENITORS
The thymic environment. For a long time the thymus has been recognized as the major site for T-cell differentiation. However, the thymus is not the only place where T cells develop. T cells are also formed in the gut, although those T cells have different characteristics that those maturing in the thymus.z6 The thymic nonlymphoid microenvironment supporting T-cell development consists of epithelial components and of mesenchymal cells present in the thymic capsule, vessels, and interlobular ~eptae.'~''~ Epithelial cells are derived from the endoderm of the third pharyngeal pouch and the ectoderm of the brachial cleft, whereas the mesenchymal cells are derived from embryonic mesoderm. As elegantly shown by Anderson et in the mouse, both mesenchymal and epithelial cells are required for T-cell development. These epithelial and mesenchymal elements may For personal use only. on November 11, 2017. by guest www.bloodjournal.org From not only provide an architectural structure for thymocyte development but also may provide cytokines andor cell surface molecules supporting T-cell development. The thymic primordia in human are formed at week 7 of ge~tation.'~ The first waves of T-cell progenitors start to populate the thymic rudiment at 7 to 8 weeks of gestation. The progenitor cells that colonize the thymus are initially derived from the yolk sac andor the liver, which is the major hematopoietic organ in the human fetus from week 7 to 22 of gestation. The human thymus is not differentiated fully before the week 15 of gestation, when the corticomedullary junction becomes visible. At that time, Hassal's corpuscles become visible in the cortex. The fact that full differentiation of the thymic organ occurs 7 to 8 weeks after colonization of the thymic primordium may suggest that the developing T cells contribute to the development of the thymic microenvironment. Indeed, in cases in which T-cell development is blocked in an early stage the thymus consists only of a cortex. Mice with defects in the recombination machinery and therefore lacking T cells and a thymic medulla show development of a medulla after repopulation of these mice with normal wildtype bone marrow cells, supporting the concept that a dialogue between developing T cells and stromal cells is required for thymop~iesis.~'
There is considerable debate concerning whether the thymus is colonized and fed by a pluripotent stem cell, a multipotential progenitor cell, or a progenitor cell that is already committed to the T-cell lineage. This question has been approached along two lines. First, it has been explored whether the blood forming organs contain progenitor cells already committed to the T-cell lineage. Second, the earliest thymic progenitors have been analyzed for their capacity to develop into hematopoietic cells other than T cells. In the next sections we will discuss evidence for and against the notion that the thymus is colonized by uncommitted progenitor cells or by cells already committed to the T-cell lineage.
Are there committed T-cell progenitors in the fetal liver and bone marrow? Studies in both humans and mice have shown that pluripotent stem cells can develop into T cells when artificially introduced in the thymus by injection. Human CD34+CD38l0"Thy-1+ cells are highly enriched for pluripotent stem ~e l l s .~*~~*~~ These cells develop into T cells in fetal thymic organs transplanted into SCID mice.' CD34+CD38'""Thy-l+ cells also develop into T cells when introduced into mouse fetal thymic lobes followed by culture in vitro (P. Res, E. Martinez Ciceras, A. C. Jaleco, K. Weyer, and H. Spits, manuscript submitted). Similarly, several groups have found in the mouse that highly enriched stem cells are able to populate a thymus after intrathymic injection in vivo."-36 These results reflect the expected capacity of stem cells to develop into T cells but do not necessarily imply that the thymus is colonized by pluripotent stem cells during the normal development process. Whether pro-thymocytes are already committed to the T-cell lineage has been addressed by searching for committed T-cell progenitors in fetal liver and fetal and adult bone marrow. Based on the idea of fixed branchpoints in development of stem cells into T cells, it was reasoned that detection of committed T-cell progenitors outside the thymus would support the notion that these cells migrate to the thymus.
Apart from the fact that this premise is not necessarily correct, most of the studies addressing this question have led to ambiguous conclusions, because there are presently no cell surface markers to conclusively distinguish T-from NK-cell progenitors. Cells expressing CD3 antigens in the cytoplasm andor CD7 are present in the fetal t h o r a~,~~,~~ fetal liver,37,39.40 and adult bone m a r r~w . "~,~~ These cells were considered by most groups to represent committed T-cell progenitors based on the fact that CD2, cyCD3, CD5, and CD7 are coexpressed on all mature T but not on all mature B cells. However, these antigens are also expressed on fetal NK cells433ez or CD34+ NK-cell progenitors from the fetal thymus,17 indicating that these antigens are not specific for early T cells. In addition, CD7 is also present on B-celP and myeloid progenitor^.'^.^^ Besides the fact that (co)expression of CD2, cyCD3, CD5, and CD7 does not define committed T-cell progenitors, there is presently no functional evidence for T-cell commitment in the fetal liver and fetal and adult bone marrow. A number of studies have shown that cyCD3+ and/or CD7+ fetal liver or bone marrow cells are able to develop into mature T cells in vitro.37,40-42.47 However, the capacity of these cells to develop into other hematopoietic cells was not investigated, precluding a conclusion with regard to T-cell commitment of these populations. In one study that examined both the myeloid and T-cell potential of CD7+ fetal liver cells, it was found that the CD7+CD34+ fetal liver cell population, which develops into T cells in an R O C , also contains primitive myeloid precursors (high proliferative potential [HPP] -colony-forming units [CFU] ).I4 These findings support the notion that expression of CD7 on CD34+ cells does not define T-cell commitment and raise the possibility that the thymus is colonized by an uncommitted multipotent progenitor cell.
It is possible that, although pro-thymocyte cells are multipotential, these cells have a restricted differentiating capacity compared with stem cells. Galy et a1 characterized a CD34+CD45RA+ lineage marker (lin)-Thy-l-cell in the human adult bone marrow able to differentiate into T and B cells in a SCID-hu mouse and to NK cells in the presence of IL-2, but unable to differentiate into myeloid cells in in vitro CFU assays (A. Galy, presented at the European Federation of Immunology Societies, Barcelona, Spain 1994). In contrast, CD34+Thy-l+ cells differentiate both to lymphoid and myeloid cells.8 The studies of Galy et a1 present the first evidence in the human that the myeloid and lymphoid developing potential of adult bone marrow cells can be separated and support the notion that stem cells are differentiated towards a more committed progenitor cell before homing to the thymus.
Recent studies in the mouse are consistent with the idea that pro-thymocytes are distinct from pluripotent stem cells but are still multipotent. Antica et a14' found a cell in the adult bone marrow with a phenotype lin-Sca-l+ that, in contrast to pluripotent stem cells, expresses Sca-2. These cells are multipotent and are capable of differentiating into lymphoid and myeloid cells, but the expansion potential was only 2% of that of Scal'Sca-2-stem cells. The Sca-2+ bone marrow progenitors could be the precursor of a thymic progenitor cell with a similar phenotype and the potential to For personal use only. on November 11, 2017. by guest www.bloodjournal.org From develop into T, B, and dendritic cells but not into myeloid ~ells:~.~' However, one other study found evidence for Tcell commitment of pro-thymocytes in the mouse. Rodewald et a152 analyzed pro-thymocytes in the peripheral blood of mouse embryos at day 15.5 of gestation. At that time the thymus is colonized, but the cells in the thymus have not progressed beyond the CD4-CD8-stage. A population was identified expressing both Thy-l and low levels of c-kit that could develop into T cells but not into B or myeloid cells, whereas another population in the fetal peripheral blood (Thy-l-c-kiPgh) possesses the capacity to develop into T-, myeloid-, and B-cell lineages. A small percentage of Thy-1' c-kit' cells had undergone DD to JP rearrangements, indicating T-cell commitment. Although Rodewald et alSz appreciate that the thymus contains primitive, noncommitted, hematopoietic progenitor cells, these investigators argue that the majority of the early thymic immigrants are already committed to the T-cell lineage before entrance into the thymus. However, it is possible that most of those cells are bipotential T/NK progenitors, not completely committed to the T-cell lineage.
In summary, no definitive evidence has been found for the existence of T-cell-committed progenitor cells in the fetal liver or the bone marrow. However, the analysis of mouse fetal blood raises the possibility that after progenitor cells leave the fetal liver or the bone marrow some of them may undergo T-cell commitment before they enter the thymus.
Early hematopoietic progenitor cells in the thymus. Analysis of hematopoietic potential of progenitor cells in the human and mouse thymus supports the concept that most early CD34+ are not committed to the T-cell lineage. We recently observed CD34hi8hCD3810w cells in the fetal thymus, representing less than 0.01% of total thymocytes. CD34+CD38'""CD45RA-cells from the fetal liver and fetal bone marrow population have been shown to be enriched for early stem However, in contrast to these stem cells, the CD34+CD38''' fetal thymocytes do not express Thy-l (P. Res, E. Martinez CAceras, A.C. Jaleco, K. Weyer, and H. Spits, manuscript submitted) and are uniformly positive for CD45RA.53 Furthermore, we detected primitive myeloid progenitor cells (HPP-CFU) in CD3-CD4-CD8-fetal thymocytes, although at a very low frequency compared with the fetal liver.I6 CD34' myeloid progenitors were found in the postnatal but myeloid progenitors were not present in the CD34+CD7+ postnatal thymocyte populatioas5 However, a proportion of the CD34h'BhCD7+ thymocytes contain bipotential T/NK progenitor^'^ (Fig l , dis- cussed below). These observations indicate that the most primitive CD34' progenitors are multipotential but are distinct from stem cells.
Similar conclusions can be derived from studies of the mouse. A cell population was found in the adult mouse thy mu^^'.^' expressing Sca-l, Thy-l .llO"', CD4'"", and c-kit but no lineage markers, similar to pluripotent stem ~e l l s .~~.~~ This population contains precursors for T and B cells,50 NK cells,s6 and dendritic cells.51 In contrast to pluripotent stem cells, these thymic progenitor cells do not have the capacity to develop into macrophages and erythrocytes." Because the developmental potential of early thymic progenitors has not been investigated in clonal assays, it is possible that CD4'"" c-&+Thy-1.1'""' murine thymic progenitors are a mixture of committed T-, B-, NK-, and dendritic-cell precursors. On the other hand, no heterogeneity was observed in phenotype of these cells using a panel of monoclonal antib~dies,~'," supporting the idea that CD4'"" c-kit' cells represent a progenitor cell population that is not yet committed to a singlecell lineage.
These studies, taken together, suggest that the thymus is colonized by multipotential hematopoietic progenitor cells distinct from stem cells. This raises the possibility that these progenitor cells can also develop into hematopoietic non-T cells within the thymus. This notion is supported by the finding that the human thymic microenvironment is permissive for development not only of T cells but also of B, NK, dendritic, and myeloid cells.I6 A similar observation has been made by Spangrude and S~o l l a y ,~~ who found that the adult mouse thymus can support myeloid development when injected in vivo with stem cell.
DIFFERENTIATION OF PRE-T CELLS TO
MATURE T
CELLS IN THE THYMUS
Transition of pre-T cells to CD3'CD4+CD8' cells. The phenotype of early thymocytes has been investigated in a large number of studies allowing a detailed picture of the changes occurring during the early stages of human T-cell development. The analysis of these stages has been facilitated by the demonstration that T-cell progenitors in the thymus are defined by the expression of CD34. As shown by Terstappen et a1," Galy et al,I3 and DiGiusto et a1," expression of CD34 decreases when cells progress during development. Thus, the relative expression of CD34 on thymocyte subsets is useful as a marker for defining different stages of thymic development. As discussed in the previous section, the earliest thymic precursors are CD34h'ghCD45RA'Thy-l-. These cells also lack CDl,S7 CD5, and CD28.I7 In addition, these cells express CD33, previously believed to define commitment to the myeloid lineage.58 This latter notion is incorrect because CD34+CD33+ thymocytes have the capacity to develop into T and NK cells.17 The earliest committed T-cell progenitor in the thymus expresses CD1, CD2, CD5, and cyCD3, but lacks CD4 and CD8 (Table 1 As yet, there is no information about expression of the pre-T-cell receptor complex in the human thymus. We found recently that approximately 50% and 5% of the CD34+TN thymocytes have rearranged TCR 6 genes and TCR P (V-D-J) genes, respectively (T. Breit, B. Blom, J. van Dongen, and H. Spits, unpublished data). Thus, the human pre-Tcell receptor complex may be expressed on the cell surface just before upregulation of CD4. As in the mouse:o371 the human TCR a gene rearranges after TCRP.92,93 The TCR 6 locus is nested within the TCR a locus, between the V a and J a gene segments. Rearrangement of the TCR a gene deletes the 6 gene. It is believed that the event initiating TCR a rearrangement links 6REC (upstream of the TCR 6 locus)
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From Table 1 . Antigen Expression at Early Stages of T-cell Development ture SP thymocytes in human (summarized in Fig 2) . The time needed to complete differentiation of immature TN thymocytes into mature SP T cells is 24 to 96 hours, as estimated from kinetic studies of TN cells injected into the human fetal thymusfliver transplant of SCID-hu mice.62 After entrance into the DP stage,"' the thymocytes acquire the CD3/TCR complex.'* The CD3'"" DP thymocytes are the main target for positive selection. The interaction of the TCWCD3 with the peptide MHC complex results in upregulation of CD3 and the activation antigen CD69.") At the CD3h'gh DP stage, the cells acquire CD27.'" In addition to acquisition of some cell surface antigens and loss of others, mRNA of the cytotoxic protein perforin and various cytokine genes are induced as well."" When these cells further mature into SP thymocytes, losing either CD4 or CD8cul ,By7 followed by CD1,yK,'"2 they switch their CD45 isotype from CD45RO to CD45RA."'*~'"' Some DP thymocytes lack CD 1 .yx.'"2 The developmental status of those CD 1 ~ DP cells is unknown. Mature thymocytes are CD3h'ghh, CD4' or CD8', CDlU2D27'CD45RA+ when they migrate out of the thymus.
Transplantation of bone marrow or fetal liver cells into SCID patients has provided evidence that the human TCR repertoire is shaped by the MHC antigens expressed in the thymic environment. Particularly informative in this respect are the observations with SCID patients transplanted with completely mismatched fetal liver or with haploidentical bone marrow.11""'2 Upon transplantation with allogeneic HLA-mismatched fetal liver, two SCID patients developed a fully reconstituted immune system with T cells of donor and B and myeloid cells of recipient origin. After immunization with tetanus toxoid (TT), TT-specific CD4' T-cell clones, all of donor origin, were obtained that recognized TT only in the context of the MHC of the recipient."" In addition, CD8+ CTL were obtained that recognize Epstein-Barr virus (EBV) antigens in the context of recipient but not donor MHC.108,109 T-cell clones specific for TT in the context of recipient MHC were also obtained from SCID patients transplanted with haploidentical maternal bone marrow cells.'"."' Thus, the TT-specific CD4' T cells and the EBV-specific CD8+ CTL were positively selected on cells, presumably thymic epithelial cells, of recipient origin. Surprisingly, in vitro studies showed a high frequency of T cells present in the peripheral blood of SCID patients, transplanted with MHC-mismatched fetal liver cells, which were cytotoxic for target cells of recipient origin and were specific for HLA antigens of the re~ipient.'"~ Recipient-reactive clones were also isolated from peripheral blood mononuclear cells (PBMC) of patients transplanted with haploidentical bone marrow."' Nonetheless, these patients did not suffer graftversus-host disease (GVHD), indicating that these recipientspecific CTL were not active in vivo. The mechanism of tolerance in these patients is not clear, but may involve ILImportantly, these observations indicate that no clonal deletion occurred in the thymus during development of the donor fetal liver stem cells. These findings could be explained by assuming that the thymus of the reconstituted SCID patients did not contain an accessory cell population of recipient origin able to cause deletion of the recipientspecific T-cell clones.'I7 Van Dongen, and H. Spits, unpublished data). We suspect that TCR (Y rearrangement is initiated at the CD3-CD4+CD8-stage, which would be consistent with observations in the mouse in which TCR a rearrangement is initiated at the CD3-CD4'"'"CD8'"" stage.95
Positive and negative selection in the human thymus.
Over the past years a wealth of information has provided insight into differentiation of CD4+CD8+ thymocytes into mature CD4' and This notion is supported by experiments of Vanderkerckhove et al"' and Schols et al.'I9 These investigators transplanted HLA-mismatched fetal liver and fetal thymus under the kidney capsule of a SCID mouse and analyzed the specificity of the mature SP thymocyte^.''^^''^ The epithelial cells of the thymus of these chimeric SCID-hu mice were derived from the thymic donor, but the hematopoietic cells, present predominantly in the medulla, were of liver origin.12' No T cells were found that recognized the HLA antigens of the fetal liver donor."' It is conceivable that hematopoietic cells of fetal liver origin (presumably dendritic cells) induced deletion of T cells with receptors specific for the MHC of the liver, but it is also possible that such cells were not positively selected because of an absence of epithelial cells of fetal liver origin. T cells specific for HLA of the thymus donor were present in the graft.'" These thymus-specific T cells were not autoreactive in vivo and were therefore tolerant towards the HLA antigens of the thymus. Incubation of these T cells with IL-2 in vitro broke the tolerance.'" These observations are similar as with the transplanted SCID patients.
Recipient-specific T cells were tolerized but not deleted and culture in IL-2 reversed the tolerance of recipient-specific T cells isolated from these patients.'" The results from these transplanted SCID patients and SCID-hu mice indicate that the human thymic epithelium can induce nonresponsiveness but not by clonal deletion.
Experiments exposing human thymocytes to superantigens have shown that, as in the mouse, these antigens can delete thymocytes expressing the relevant TCR V@. Merkenschlager and Fisher"' reported that the addition of Staphylococcal enterotoxin (SE) D to a mousehuman FTOC deleted Vp 5.215.3-positive T cells, whereas two other groups reported that injection of SEB in the thymus of SCID-hu mice removed most of the human thymocytes expressing Vp chains interacting with this s u p e~a n t i g e n .~~~. '~~ These data suggest that the human thymic environment can mediate clonal deletion.
Signal transduction pathways involved in positive and negative selection are not yet completely understood. Tyrosine phosphorylation plays a critical role in signalling Initially, the idea that T and NK cells are closely related was based on a number of phenotypic and functional characteristics common to T and NK cells but not to B cells (summarized in Table 2 ). Most remarkable is the expression of CD3 y , S E , and 6 in human fetal NK cell^.^'^'^^ Because of their association with TCR proteins and the failure to detect CD3 proteins in mature NK and B cells, it was assumed in the past that CD3 was expressed exclusively by T cells. However, although adult NK cells do not express significant levels of cytoplasmic CD3 protein (except for CD35135"38), CD3t mRNA134,'3y and protein'34 are rapidly upregulated in these cells after activation in the presence of interleukin-2 (IL-2). Recently, Wang et all4" also found evidence for expression of CD3t in the mouse NK cells and a possible role for CD3t in T-and NK-cell development. Transgenic mice carrying 30 or more copies of the human CD3t gene exhibit an absolute block in T-and NK-cell development, whereas in the B cells, myeloid and erythroid development was unaffected. Moreover, the endogenous mouse CD36 was detected in IL-2-activated NK cells from normal mice.14' Taken together, these results suggest that overexpressed human CD3r acts as a dominant negative, possibly affecting ;L signal that is necessary for early T and NK development. However, the extracellular domain of CD3t apparently is not required for NK-cell development because normal NK cells are present in mice deficient in expression of CD3r (E. Vivier, personal communication, January 1995).
Importantly Moreover, all clones analyzed had their TCR p and y genes in germline configur a t i~n .~" Interestingly, such clones can also be established from fetal liver." These CD3-CD56-clones express high levels of cyCD3y, b, and t and proliferate in response to IL-2, IL-4, IL-7, and IL-3.44 Most of the fetal thymic CD3-CD56-clones also respond to these cytokines (H. Spits, unpublished data). These findings suggest that these CDTCD56-clones represent committed NK-cell progenitors.
Recently, the presence of CD34' NK progenitors in the thymus was reported. CD34h'gh thymocytes lacking CD 1, 3, of each clone were cultured further in the cytokine mixture, whereas the other half were pooled and tested for the ability to differentiate into T cells in an R O C . When cultured in SCF, IL-2, and IL-7, almost 100% of the clones developed into CD56' NK cells, whereas these same clones developed into T cells in an FTOC." These experiments present evidence for the existence of bipotential T/NK progenitors. In contrast to the high frequency of NK progenitors, the frequency of primitive myeloid cells (HPP-CFU) among these CD34high thymic progenitors was less than 1%. Thus, the majority of these progenitors are not pluripotent. It was not determined whether the CD34figh T/NK-cell precursors also have B-cell developmental potential. But a substantial proportion of these progenitor cells express cyCD3; therefore, it is unlikely that those cyCD3+ cells can develop into B cells. Thus, the findings of Sbchez et a14' suggest that many of the thymic CD34high progenitor cells can develop only to T and NK cells and not to any other cell type, underscoring the close relationship of NK with T cells. Sites of NK-cell development. The demonstration that the thymus contains bipotential T/NK progenitors, committed NK precursors, and mature NK cells and the fact that the human fetal thymic microenvironment is permissive for NK development16 indicate that NK differentiation can occur in the thymus. However, the thymus is not required for human NK development because NK cells are already present in the human fetal liver before formation of the thymic prim0rdiurn.4~ Consistent with this finding is the fact that athymic, nude mice have normal numbers of NK cells in the periphery.
It is likely that the bone marrow is the main site for NK-cell development. Studies from several laboratories have shown that human NK ce11s19~21~154~155 and rat NK cells'56 can differentiate from immature bone marrow progenitors in long-term bone marrow cultures. Human NK cells have been generated from either CD34-154 or CD34+ bone marrow p o p~l a t i o n s~~~~'~~~~ and these progenitors are heterogeneous with respect to expression of HLA-DR and CD7. Stromal cells were required for NK-cell development in certain culture systems" but not in others." This is possibly related to the maturity of the progenitor examined because primitive CD34TD7-lin-progenitors required contact with stroma for NK differentiation, whereas the more mature CD34+CD7+ progenitor cells could differentiate into NK cells in the absence of contact with stroma.'55 Nonetheless, in all experimental models, NK-cell development in vitro required the presence of IL-2. As in other lineages, CD34 expression was lost upon NK-cell differentiation and the cells acquired the expression of CD2, CD16, CD56, and other membrane antigens present on mature peripheral blood NK cells.
Mature NK cells are present before population colonization of the bone with stem cells:' Moreover, CD34high cyCD3+ cells that may represent NK progenitors are present in the liver.17 Given the fact that both the fetal liver and adult bone marrow also contain pro-and pre-B cells,'57 it is possible that, similar to B cells, NK cells develop in the liver during fetal life and subsequently in the bone marrow after colonization of the bone marrow with stem cells. However, it can presently not be excluded that NK cells can also develop in other organs (eg, spleen, liver, or blood). Resolution These observations imply that NK cells possess specific receptors for MHC class I molecules and that interaction between these receptors and MHC class I molecules on target cells inhibits NK-cell-mediated cytotoxicity. In the mouse, Yokohama et a1 identified an NK-cell receptor (designated Ly-49A) on a subset of NK cells in certain mouse strains that binds to H-2Dd,'6"16s thereby preventing lysis of target cells expressing H-2Dd.Ib3 Recently, NK-cell receptors for polymorphic HLA-B'66 and HLA-C"' molecules have also been identified on subsets of human NK cells. NK cells bearing these receptors are unable to kill target cells expressing the appropriate HLA class I alleles. Because NK cells do not lyse normal autologous cells, it is assumed that all NK cells in an individual will express an NK-cell receptor that can recognize at least one self MHC class I allele. These NK-cell receptors may prevent the initiation of cytolysis by transmitting a "negative signal," but the molecular mechanism of this process is unknown.
Mice with disrupted P2-microglobulin genes".'" or TAP-1 genes"* (encoding proteins that transport peptides from the cytoplasm to the ER for assembly with MHC class 1 molecules) possess normal numbers of NK cells, despite reduced levels of MHC class I expression in these aniclass I molecules is not necessary for the generation of NK cells. However, the cytolytic activity of the NK cells in these mutant mice is substantially reduced compared with normal mice, suggesting that NK-cell maturation may be affected by the diminished expression of MHC class I molecules.16"~'h'~'6x Presently, it is unknown when in development NK cells first express these MHC class I receptors and whether self MHC class I alleles influence the acquisition of an "NK-cell receptor repertoire." Undoubtedly, these questions will receive considerable attention in the near future. mals,16~l,lhl.lhR Therefore, normal expression of self MHC
THE ROLE OF CYTOKINES IN T-AND NK-CELL DEVELOPMENT
Certain combinations of various cytokines including c-kit ligand (SCF), IL-I, IL-3, IL-6, and the colony-stimulating factors (GM-CSF, G-CSF, and M-CSF) induce proliferation and differentiation of stem cells into myeloid cells in It was therefore suspected that cytokines are also involved in lymphoid development. Early work addressing the possible involvement of cytokines in T-cell development vitr0.169-171 focused on IL-2 and IL-4. However, although these cytokines may induce differentiation of human T-cell progenitors into mature T cells in some in vitro assay^,"*^'^^ the presence of normal numbers of CD4' and CD8' mature T cells in the circulation of immunodeficient patients whose cells lack the capacity to synthesize IL-2'76"7x is consistent with the existence of an IL-2-independent T-cell differentiation pathway in human. Moreover, the presence of a normal thymus and of mature T cells in mice deficient for IL-2. IL-4, or both support the notion that IL-2 and IL-4 are not critical for thymic T-cell although an immunodeficiency ensues in IL-2 -1-mice.'x2 Other cytokines such as IL-6 have also been implicated in T-cell development, but normal intrathymic T-cell development is observed in IL-6 -1-mutant mice.'"
The same holds true for mice deficient in the IFNyR,IX4 indicating that IFNy is dispensable for thymic T-cell development as well.
Recently, it was conclusively demonstrated that cytokines are indeed critical for T-cell (and also NK-cell) development when the molecular defect of X-linked severe combined immunodeficiency was identified.Ixs These X-SCID patients present a severe block in T-and NK-cell development, whereas normal or even elevated numbers of B cells are present in their circulation. Normal numbers of nonlymphoid hematopoietic cells were present in these patients. The molecular defect in these patients was pinpointed to mutations in the gene encoding the third chain of the IL-2 receptor located on the X chromosome region q13-1.'X"'RX Several mutations of this gene have been identified,""'"" all of them resulting in a loss of function of the IL-2 receptor complex. The IL-2R y chain was originally identified as part of the trimolecular complex that forms the high-affinity ILIt is now known that the 1L-2R y chain is also an element of the IL-4, IL-7, and IL-15 receptor^.^^^^''' Based on these observations, the IL-2R y chain has been designated yc, for common y chain.
Which of the cytokines that share the y c chain are important for development of T and NK cells? As explained above, it is not likely that IL-2 andor IL-4 are the ligands of the yc chain that are essential for T-and NK-cell development. A good candidate is IL-7. This cytokine promotes the growth of murine pre-B and of immature TN mouse thymocytes.z""~2"2 IL-7 also supports growth of immature CD34' TN human thymocytesss.6".2"'.2M and is a powerful growth factor for mature murinezos and human T mouse pre-B cells, the efficacy of IL-7 in supporting human pre-B cell proliferation is very modest, but the IL-7 response of human pre-B cells is enhanced by IL-3.2"R IL-7 can also mediate differentiation of human CD34'CD5-thymic prec u r s o r~,~~ and bone marrow progenitors" into CD56' NK cells in combination with IL-2 and SCF. Evidence that IL-7 is involved in murine T-and B-cell development comes from studies with neutralizing anti-IL-7 antibodies. Anti-IL-7 partly blocks T-cell development of day-14 murine thymocytes in an FTOC.209 When injected in utero, anti-IL-7 monoclonal antibodies strongly block development of B cells and partially inhibit thymic T cells in vivo.2"' The latter study showed that anti-IL-7 affected all thymic subsets.
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Other indications that IL-7 is instrumental in T-cell development come from studies using neutralizing anti-IL-7 receptor antibodies and an analysis of mice with a targeted deletion in the IL-7Ra chain. Whereas an anti-IL-7Ra antibody partially inhibits T-cell development from primitive CD44+c-kit+ thymic progenitors in an R O C , a combination of this antibody with an anti-yc antibody strongly blocks in vitro T-cell development.2'' A heterogeneous phenotype with respect to thymic T-cell development is observed in the IL-7Ra -/-
The cellularity of the thymus varies between 0.01% to 10% of the wild-type. Those with only a few thymocytes have relatively more CD4-CD8-cells and showed a block at the TN CD25-Thus, transition from CD25-to CD25+ cells and the accompanying cellular expansion is blocked. In cases in which the cellularity of the thymus is 1 % or more of the wild-type number, the distribution of CD4'CD8+ cells in the thymus is normal. The cellularity in the spleen is 10% of wild-type in all IL-7Ra -/-
The IL-7Ra-deficient mice manifest a near complete block in B-cell development, but these mice were not tested for the presence of NK cells. The findings that fresh thymic stromal cells express IL-7 mRNA and IL-7 protein209 and h~m a n~'~~~'~ and mouse thymic stromal cell express IL-7 mRNA and produce IL-7 protein in vitro are consistent with a role for IL-7 in thymic T-cell development.
Recently, mice with a targeted deletion of the yc chain were generated2I6 (P. Krimpenfort, B. Blom, H. Spits, and A. Berns, unpublished data). These mice have substantially reduced numbers of T and B cells and no detectable NK cells. The deficiency of T and NK cells in the yc -/-mice is consistent with the observations in X-SCID di~ease.~" But whereas these patients have normal or even elevated numbers of B cells compared with normal healthy individual^:'^ the yc-deficient mice have reduced numbers of B cells. This finding indicates that human B cells can develop independently of the yc chain. Perhaps in contrast to mouse B cells, human pre-B cells do not require IL-7 in vivo. This possibility is consistent with the rather inefficient in vitro expansion of human pre-B cells in the presence of IL-7 when compared with mouse pre-B cells.208 Taken together, these findings show that there seems to be strong evidence that IL-7 is involved in T and NK development.
Two hypotheses have been put forward to explain the action of cytokines in development of hematopoietic cells: the stochastic and inductive models!.218 In the stochastic hypothesis it is argued that multipotent progenitor cells do not require cytokines or other inductive signals to differentiate into lineage-committed cells. Cytokines are necessary to maintain proliferation and/or viability of the progenitor cells. By contrast, the inductive hypothesis is based on the premise that external signals induce a genetic program resulting in lineage commitment and further differentiation. External signals may be provided by cytokines and/or cellular adhesion molecules and the extracellular matrix. A problem with experimental approaches to prove or disprove these hypotheses is that addition of cytokines is required for cell survival. In a recent study this difficulty was overcome by transfecting bcl-2 into progenitor cells.218 Multipotential progenitor cells, saved from apoptotic death by transfection of DNA encoding bcl-2, differentiate in the absence of cytokines.218 This result argues in favor of the stochastic hypothesis. Similar experiments have not yet been performed to investigate whether IL-7 acts to promote survival or as an inducer of lymphoid differentiation. However, data both from human and mouse studies suggest that the IL-7 may be an inductive factor. In an analysis of rearrangements of the TCR p locus in X-SCID patients, D p to JP rearrangements were detected, but the thymocytes of these patients lack Vp to DJ0 rearrangement~.~'~ Furthermore, it was reported that IL-7 induces V(D)J rearrzngement of the TCR p locus in thymocytes from mouse embryos at day 14 of gestation, whereas 15 other factors, including L-1, IL-2, and IL-4, failed to induce TCR rearrangement.220 However, IL-7 is the only factor that was able to maintain RAG expression in cultured day-l4 thymocytes, raising the possibility that IL-7 allowed gene rearrangements to proceed rather than inducing them. In another study it was found that culturing day-l4 mouse fetal liver cells for 7 days in IL-7 induces functionally rearranged TCR y transcripts.22' Additionally, IL-7 induces RAG-l and RAG-2 transcripts in these fetal liver cultures. IL-7-induced TCR y transcripts were also observed in the presence of the growth-inhibiting agent hydroxyurea, excluding the possibility that IL-7 induces outgrowth of a small population expressing TCR y transcript.221 However, none of those studies excludes the possibility that IL-7 does not directly induce TCR gene rearrangement but promotes survival of the cells that rearrange their receptors.
Engagement of the yc chain is required but probably not sufficient for T-and NK-cell development. Recent data from murine studies suggest that SCF is also involved in early stages of T-cell differentiati~n.~~.'~~ The c-kit receptor is expressed on stem cells and early thymic T-cell progenitors. SCF is expressed in the embryonic mouse thymus.209 SCF enhances proliferation of thymic T-cell progenitors in response to IL-7 both in mouse and human. Antibodies against c-kit inhibit development of mouse fetal liver cells in an FTOC.56.222 It is not entirely clear whether c-kit is involved in T-cell development after progenitors have migrated into the thymus.
The role of SCF in human T-cell development has not yet been studied in detail, although some data suggest that SCF augments development of human T and NK cells. SCF is produced by cultured human thymic epithelial cells2I3 and increases the response of human CD34+ TN thymocytes to IL-7. Interestingly, the IL-7 response of CD3-CD4TD8-immature thymocytes is not enhanced by SCF (H. Spits, unpublished data). Culturing CD34+ thymic precursors in the combination of SCF, IL-7, and IL-2 results in development of NK cell^.'^,^'
CONCLUSION
The developmental pathways of pluripotent stem cells to mature T and NK cells are being elucidated, although many gaps in our understanding of these pathways have yet to be filled. Recent studies have improved our understanding of the developmental relationship of T and NK cells. It is likely that the common T/NK progenitor just upstream of committed T-and NK-cell precursors cannot develop to B cells.
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From However, the cellular stages between the pluripotent stem cell and the common T/NK progenitor cell are still unknown. The observation that a deficiency in the y c chain leads to severe disturbances in development of all three lymphoid lineages whereas development of other hematopoietic cells is not affected supports the idea that T, B, and NK cells develop from a common progenitor cell. This notion is further substantiated by the lack of T, B, and NK cells in mice deficient in the transcription factor Ikaros.' However, the common lymphoid progenitor cell has yet to be precisely defined in terms of expression of cell surface antigens to distinguish these cells from myeloid and erythroid progenitor cells. Characterization of the common lymphoid progenitor and more detailed knowledge of the candidate common thymic T/NK-cell progenitor is required for an understanding of the molecular mechanisms governing Tand NK-cell commitment and will remain a challenge ahead. Compared with T lymphocytes, the differentiation pathways of NK cells with respect to their recognition of self MHC molecules and development of functional subsets are not understood and will undoubtedly be the subject of considerable research efforts. The identification of the IL-7Wyc complex as a critical component in T-and NK-cell development will be the basis for improving our understanding of the role of cytokines in this development and may also lead to the development of methods to expand TNK-cell progenitors in vitro. These cultured progenitor cells may be used as a therapeutic modality in T-cell replacement therapy in congenital or acquired immunodeficiencies.
Although not discussed in this review, the improved comprehension of different cellular stages in T and NK development will perhaps also provide a more refined staging of Tlineage ALL.
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